ATRX and neoplasm: Since the discovery that ATRX is often lost in ALT-(alternative lengthening of telomeres) positive tumours (3), studies on the molecular mechanism by which ATRX suppresses the ALT pathway in cancer (4) far outnumber those on its roles in development.